Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
It helps convert nutrients into ATP, the energy currency of the body
Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation
Baseline bloodwork CBC, CRP, ferritin, IL-6, cortisol AM, metabolic panel, thyroid function Cardiovascular assessment heart rate variability, orthostatic vitals if POTS is suspected Gut health markers stool testing, zonulin, calprotectin if GI symptoms are prominent Mitochondrial function proxies lactate, organic acids panel if PEM is a primary complaint From there, a typical protocol might be structured as: Phase 1 (Weeks 16): Immune and gut foundation Thymosin Alpha-1: 1.6 mg subcutaneous, twice weekly BPC-157: 250500 mcg daily, route determined by predominant symptom (oral for gut, injectable for systemic) Phase 2 (Weeks 412): Tissue repair and cardiovascular recovery TB-500: 2.02.5 mg subcutaneous, twice weekly Continue BPC-157 as indicated Phase 3 (Weeks 816): Maintenance and metabolic support Taper or pulse doses based on clinical response Add mitochondrial support if fatigue persists (see: Mitochondrial Peptides and Insulin Resistance) These are illustrative dosing ranges based on clinical research and published protocols
Supplementing with additional B12 in this population has not been consistently shown to produce meaningful improvements in anxiety or mood on its own
BPC-157 is not FDA-approved for any human therapeutic use, and this article does not claim that ProHealth BPC-157 Ultra Probiotic diagnoses, treats, cures, or prevents any disease
US$ 26.96
US$ 25.64
US$ 25.14
US$ 20.72
US$ 21.40